Italia markets close in 1 hour 41 minutes
FTSE MIB
33.966,53 -392,30 (-1,14%) Dow Jones
38.520,57 -191,64 (-0,50%) Nasdaq
17.736,00 +127,56 (+0,72%) Nikkei 225
38.720,47 -156,24 (-0,40%) Petrolio
78,66 +0,16 (+0,20%) Bitcoin EUR
62.891,32 -1.448,62 (-2,25%)
TEVA Jan 2025 12.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 10:52AM EDT. Mercato aperto.
| Chiusura precedente | 5,93 |
| Aperto | 6,05 |
| Denaro | 5,50 |
| Domanda | 5,95 |
| Prezzo d'esercizio | 12,00 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 5,93 - 6,05 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 11,31k |
GlobeNewswireTeva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.
© 2024 Yahoo. Tutti i diritti riservati.